COMMUNIQUÉS West-GlobeNewswire

Hydropothecary launches a new brand for recreational cannabis: Introducing HEXO
24/05/2018
The company announces application to graduate to the Toronto Stock Exchange TORONTO, May 24, 2018 (GLOBE NEWSWIRE) -- The Hydropothecary Corporation (TSXV:THCX) (“Hydropothecary” or “The Company”) today introduced HEXO [...]
Hydropothecary lance une nouvelle marque de cannabis récréatif : HEXO
24/05/2018
L’entreprise annonce une demande d’inscription pour passer à la Bourse de Toronto TORONTO, 24 mai 2018 (GLOBE NEWSWIRE) -- Aujourd’hui, la Société Hydropothecary (TSXV:THCX) (« Hydropothecary » ou la « Société ») a [...]
CEPI Awards $25 Million Contract to Profectus BioSciences and Emergent BioSolutions to Develop Nipah Virus Vaccine
24/05/2018
OSLO, Norway and BALTIMORE and GAITHERSBURG, Md., May 24, 2018 (GLOBE NEWSWIRE) -- CEPI—the Coalition for Epidemic Preparedness Innovations—today announced a collaboration with Profectus BioSciences, Inc. and Emergent [...]
BioCryst Pharmaceuticals and Idera Pharmaceuticals to Present at the Jefferies 2018 Global Healthcare Conference
24/05/2018
RESEARCH TRIANGLE PARK, N.C. and EXTON, Pa., May 24, 2018 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (“BioCryst”) (NASDAQ: BCRX ), and Idera Pharmaceuticals, Inc. (“Idera”) (NASDAQ: IDRA ), today announced that [...]
PRA Named International Clinical Research Company of the Year
24/05/2018
RALEIGH, N.C., May 24, 2018 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH ) is pleased to announce it was recognized by PharmaTimes as the International Clinical Research Company of the Year. This is the [...]
Helsinn announces EUR6 million investment in Helsinn Birex Pharmaceuticals to safeguard the quality and authenticity of its products
24/05/2018
Helsinn announces EUR6 million investment in Helsinn Birex Pharmaceuticals to safeguard the quality and authenticity of its products Lugano, Switzerland, May 24, 2018 – Helsinn, a Swiss pharmaceutical group focused on [...]
Real-world evidence shows clinically meaningful weight loss in people receiving Saxenda®
24/05/2018
Vienna, Austria, 24 May 2018 - People treated with Saxenda ® (liraglutide 3 mg) for weight management lost an average of 8.1 kg after six months in a real-world clinical setting, in combination with diet and exercise. [...]
Independent Stent Imaging Study Shows Excellent Healing Profile with Resolute Onyx DES in Complex Patients with Coronary Artery Disease
24/05/2018
Onyx 1-Month OCT Study Provides Potential Insights on DAPT Duration in Complex Patients Following Stent Implantation DUBLIN and PARIS- May 24, 2018 - Investigators today unveiled clinical data from the independently run [...]
Independent Stent Imaging Study Shows Excellent Healing Profile with Resolute Onyx DES in Complex Patients with Coronary Artery Disease
24/05/2018
Onyx 1-Month OCT Study Provides Potential Insights on DAPT Duration in Complex Patients Following Stent Implantation DUBLIN and PARIS- May 24, 2018 - Investigators today unveiled clinical data from the independently run [...]
Immunicum AB: Invitation to Investor Event
24/05/2018
Press Release 24 May 2018 Immunicum AB: Invitation to Investor Event Immunicum AB (publ; IMMU.ST) announced today that the Company will host an investor event in Kalmar on June 13 starting at 18:00 CEST. Carlos de Sousa [...]
Shire plc : Rule 2.9 Announcement
24/05/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 24 May 2018 Shire [...]
Saniona publishes its interim report for the first quarter 2018
24/05/2018
PRESS RELEASE May 24, 2018 Financial highlights Q1 2018 (Q1 2017) Net revenues were SEK 4.3 M (7.5 M) EBIT was SEK -15.7 M (-7.6 M) Net profit/loss was SEK -13.5 M (-6.4 M) Earnings per share were SEK -0.62 (-0.31) [...]
Bavarian Nordic Announces Interim Results for the First Three Months of 2018
24/05/2018
COPENHAGEN, Denmark, May 24, 2018 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today its interim financial results and business progress for the first three months of 2018. First quarter highlights and [...]
Sandoz receives European Commission approval for Zessly® (infliximab) in gastroenterological, rheumatological and dermatological diseases
24/05/2018
European Commission's (EC) approval based on comprehensive data package confirming that Zessly ® matches safety, efficacy and quality of reference medicine Biosimilars such as Zessly enable earlier patient access to [...]
Scholar Rock Announces Pricing of Initial Public Offering
24/05/2018
CAMBRIDGE, Mass., May 23, 2018 (GLOBE NEWSWIRE) -- Scholar Rock (NASDAQ: SRRK ), a biopharmaceutical company focused on the discovery and development of innovative medicines for the treatment of serious diseases in [...]
Arcturus Therapeutics Comments on Court Ruling on Undisclosed Group Organized by Joseph E. Payne and his Associates in Violation of Regulation 13D
24/05/2018
California Federal Court Rules that Arcturus is Likely to Succeed on Merits of its Claims Against Payne Further Violations by Payne and His Associates Enjoined to Permit all Arcturus Shareholders to Have a Fully [...]
Kiniksa Pharmaceuticals, Ltd. Announces Pricing of Initial Public Offering
24/05/2018
HAMILTON, Bermuda, May 23, 2018 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (“Kiniksa”) announced today the pricing of its initial public offering of 8,477,777 Class A common shares at a public offering price of $ [...]
Melinta Therapeutics Announces Pricing of Public Offering of Common Stock
24/05/2018
NEW HAVEN, Conn., May 23, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT ), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial [...]
Allscripts to deliver anesthesia solution across SingHealth healthcare institutions
24/05/2018
SINGAPORE, May 23, 2018 (GLOBE NEWSWIRE) -- Singapore’s largest public healthcare group, SingHealth, has partnered with Allscripts (NASDAQ: MDRX ) to implement iPro Anesthesia across the Group. The advanced software [...]

Pages